| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
ING2 |
ING2, ING1L: Inhibitor of growth protein 2 |
2.812 |
Evidence |
|
| RAP2A |
RAP2A: Ras-related protein Rap-2a precursor |
PRKX |
PRKX, PKX1: Serine/threonine-protein kinase PRKX |
2.812 |
Evidence |
|
| CSTF2 |
CSTF2: Cleavage stimulation factor 64 kDa subunit |
UBQLN3 |
UBQLN3: Ubiquilin-3 |
2.812 |
Evidence |
|
| DVL2 |
DVL2: Segment polarity protein dishevelled homolog DVL-2 |
JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
2.812 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
PRKCH |
PRKCH, PKCL, PRKCL: Protein kinase C eta type |
2.812 |
Evidence |
|
| HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
CBX1 |
CBX1, CBX: Chromobox protein homolog 1 |
2.812 |
Evidence |
|
| KIF3B |
KIF3B, KIAA0359: Kinesin-like protein KIF3B |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
2.812 |
Evidence |
O
|
| SLC2A14 |
SLC2A3, GLUT3: Solute carrier family 2, facilitated glucose transporter member 3 |
AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
2.807 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
AQP2 |
AQP2: Aquaporin-2 |
2.805 |
Evidence |
|
| AQP2 |
AQP2: Aquaporin-2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
2.805 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
SALL1 |
SALL1, SAL1: Sal-like protein 1 |
2.805 |
Evidence |
|
| TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
2.805 |
Evidence |
|
| SLC4A1 |
SLC4A1, AE1, DI, EPB3: Band 3 anion transport protein |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
2.805 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
NPR2 |
NPR2, ANPRB: Atrial natriuretic peptide receptor B precursor |
2.805 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
2.805 |
Evidence |
|
| AQP2 |
AQP2: Aquaporin-2 |
SYK |
SYK: Tyrosine-protein kinase SYK |
2.805 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
HYAL2 |
HYAL2, LUCA2: Hyaluronidase-2 precursor |
2.805 |
Evidence |
|
| GDF8 |
MSTN, GDF8: Growth/differentiation factor 8 precursor |
LEFTY1 |
LEFTY1, LEFTB, UNQ278/PRO317, LEFTYB: Left-right determination factor 1 precurso |
2.805 |
Evidence |
|
| ZNF273 |
|
ZNF410 |
IPI00009618 |
2.805 |
Evidence |
|
| ZNF93 |
ZNF93, ZNF505: Zinc finger protein 93 |
ZNF3 |
|
2.805 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
PCDHGB4 |
IPI00028619 |
2.805 |
Evidence |
|
| ADAMTS2 |
ADAMTS2, PCINP, PCPNI: ADAMTS-2 precursor |
NID2 |
NID2: Nidogen-2 precursor |
2.805 |
Evidence |
|
| TLR7 |
TLR7, UNQ248/PRO285: Toll-like receptor 7 precursor |
IRAK3 |
IRAK3: Interleukin-1 receptor-associated kinase 3 |
2.805 |
Evidence |
|
| TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
WDR13 |
WDR13: WD repeat-containing protein 13 |
2.805 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
FYN |
IPI00640091 |
2.805 |
Evidence |
|
- 
-